Physicians' Academy for Cardiovascular Education
Meeting Impression: Heart failure, Diabetes, and Renal Dysfunction: Time for a more unified approach

Meeting Impression: Heart failure, Diabetes, and Renal Dysfunction: Time for a more unified approach

News - May 1, 2017

See below to download the Meeting Impression This lunch symposium held during ESC Heart Failure 2017 explored mechanisms and common pathways underlying the development of cardiovascular disease (CVD) and heart failure (HF) and the particular risk of patients with diabetes. Innovation in the field of HF management is ongoing. This has yielded several new agents in recent years, which are likely to change clinical practice. The role of anti-diabetic therapy, in particular the use of SGLT2 inhibitors, was discussed in the context of a risk-based intervention strategy that targets glucose control and CV risk factors.

Disclosures

Funding

This satellite symposium was organised by the PACE Foundation and sponsored by an unrestricted educational grant of Boehringer Ingelheim/Lilly.

Download Meeting Impression View lecture - Challenges in Heart Failure management: Diabetes and Renal Impairment - by Prof. Martin Cowie View lecture - SGLT2 inhibition & Heart Failure: Lessons from EMPA REG Outcome - by Prof. Per Henrik Groop

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: